Try our Advanced Search for more refined results
Intellectual Property
-
February 20, 2026
2nd Circ. Backs $286K For Childish Gambino's Attys
The Second Circuit has approved a $286,000 attorney fee award granted to lawyers representing rapper Childish Gambino and his record label in a case from another rapper who alleged part of the hit song "This Is America" was lifted from one of his tracks.
-
February 20, 2026
UK Litigation Roundup: Here's What You Missed In London
The last week in London saw the founders of Getir sue investment fund Mubadala for more than $700 million tied to alleged breaches during the company's restructuring, the Welsh Rugby Union face a claim by Swansea Council over a proposed takeover of Cardiff Rugby, and Euro Car Parks target the Competition and Markets Authority after it was fined by the watchdog. Here, Law360 looks at these and other new claims in the U.K.
-
February 19, 2026
Ex-Google Engineers Took Trade Secrets To Iran, DOJ Says
Three Silicon Valley engineers exploited their employment at Google and other major tech companies in order to steal trade secrets and send the confidential information to personal devices that they then accessed in Iran, the U.S. Department of Justice said Thursday.
-
February 19, 2026
Lab Seeks Rare Essential Patent Injunction In Wi-Fi Case
Citing recent encouragement from federal agencies, a Korean research lab is seeking a rare permanent injunction in a case involving standard essential patents, after a unit of Taiwan's Asus stipulated that its routers infringe the lab's essential Wi-Fi patents.
-
February 19, 2026
Trump's Push For Airport TMs Unprecedented, Experts Say
President Donald Trump's effort to register trademarks for airports that could someday bear his name represents a striking break from how past presidents have gotten their names placed on landmarks, intellectual property attorneys say.
-
February 19, 2026
Justices Urged To Bar Passive Infringement For Skinny Labels
The Federal Circuit cleared the path for branded-drug makers to claim a rival induced infringement of a patent without taking any active steps to do so, Hikma told the U.S. Supreme Court in a case over so-called skinny labels.
-
February 19, 2026
Producers Drop Karol G 'Gatúbela' Suit, Issue Apology
Two music producers who accused star Colombian singer Karol G and Universal Music Group of lifting the beat from their track for her hit song "Gatúbela" told a Florida federal court Wednesday that they are dropping their claims and will publicly apologize.
-
February 19, 2026
Funder Longford Wins Patent Litigation Settlement Dispute
Litigation funder Longford Capital has prevailed in arbitration relating to a dispute with Arigna Technology Ltd. over a settlement that ended certain patent litigation, according to documents filed in Delaware federal court.
-
February 19, 2026
Judge Affirms Literal Infringement In Ravgen's $57M Jury Win
A Texas federal judge has upheld a jury's finding that genetic testing company Natera Inc. committed literal infringement of a patent held by Ravgen Inc., but said Ravgen's expert testimony wasn't enough to support the jury's finding of infringement under the doctrine of equivalents.
-
February 19, 2026
Shkreli Again Tries To Add Wu-Tang Members To Album Fight
"Pharma Bro" Martin Shkreli filed a third-party complaint against two members of hip-hop group Wu-Tang Clan, seeking once again to bring them into litigation brought by a cryptocurrency community that claims Shkreli improperly retained copies of a Wu-Tang album the community had bought the rights to.
-
February 19, 2026
Flavored Air Co. Seeks Ch. 15 Nod In Nevada After Settlement
A Canadian flavored air device company is asking a Nevada bankruptcy judge to recognize the Canadian insolvency proceedings it began earlier this month after falling behind in payments from the settlement of a U.S. trademark infringement suit.
-
February 19, 2026
She Has A Point: Dechert's Kassie Helm
Kassie Helm, co-chair of Dechert LLP's global intellectual property group and head of its IP litigation group, is "unquestionably one of the leading lights of her generation," according to Morrison Foerster LLP partner Daralyn Durie, who praised Helm for her work as opposing counsel in a new series celebrating women litigators.
-
February 19, 2026
Squires Accepts 8 PTAB Cases, Walks Back 7 Merits Referrals
A bulk summary order from U.S. Patent and Trademark Office Director John Squires granted eight petitions for America Invents Act patent challenges while denying 14 others, including seven that he had previously accepted for merits-based review.
-
February 19, 2026
Fed. Circ. OKs Decision Clearing Sony In $500M Patent Case
The Federal Circuit on Thursday upheld a decision that Sony's PlayStation controllers do not infringe a computer input device patent, in a case where Sony said patent owner Genuine Enabling Technology was seeking nearly $500 million in damages.
-
February 19, 2026
Fed. Circ. Won't Revive Corcept's Drug Patent Feud
The Federal Circuit on Thursday declined to revive a case from Corcept Therapeutics Inc. in which it accused Teva Pharmaceuticals USA Inc. of patent infringement over its production of a generic version of the drug Korlym, saying a district judge didn't make a clear error in ruling Corcept hadn't shown any infringement.
-
February 19, 2026
Foley & Lardner Brings On 4 IP, Corporate Attys In Calif.
Foley & Lardner LLP is expanding its California team, announcing Thursday it is adding four partners with technology-related experience — two in San Diego, one in San Francisco and one in Silicon Valley.
-
February 19, 2026
Tech Co. Seeks Morgan Lewis DQ From Smart Glasses Case
A Hong Kong-based tech company has asked a Massachusetts federal judge to kick Morgan Lewis & Bockius LLP off of a case in which it's accusing Meta Platforms and Oakley Inc. of infringing patents with their smart glasses technology.
-
February 19, 2026
TD Garden Owners Say Pot Shops Copying Name
The company that owns Boston sports and entertainment venue TD Garden says a cannabis retail chain is infringing its trademarks by doing business as "The Boston Garden Dispensary," in an infringement lawsuit filed on Wednesday in Massachusetts federal court.
-
February 19, 2026
UK Raises Antitrust Concerns In Getty's Shutterstock Deal
The U.K.'s antitrust authority said Thursday that it has provisionally found that Getty Images' planned $3.7 billion acquisition of Shutterstock could harm the supply of editorial images in Britain.
-
February 18, 2026
Judge Won't Let MediaTek Out Of Bogus Litigation Case
A California federal judge won't grant Taiwanese semiconductor maker MediaTek Inc. a win in a lawsuit from Taiwanese competitor Realtek accusing the former of colluding with other companies to harass Realtek with bogus patent cases, saying a Texas federal judge's ruling that denied Realtek sanctions in a case there didn't mean the baselessness of the case couldn't be relitigated.
-
February 18, 2026
Sandoz's Case Against Amgen Over Enbrel Biosimilar Tossed
A Virginia federal court found that Sandoz Inc. should have brought its claims accusing Amgen of blocking competition for Enbrel in a previous patent dispute over the blockbuster autoimmune disease treatment.
-
February 18, 2026
Sen. IP Leads Worry About Outsize Standards Influencers
U.S. senators who lead the Judiciary Committee's subcommittee on intellectual property wrote to the head of the American National Standards Institute stressing "the essential importance of integrity, balance and transparency" while developing standards in the U.S.
-
February 18, 2026
NC Biz Court Slashes Tex-Mex Chain's Trade Secrets Case
The former manager of an upscale Tex-Mex restaurant in North Carolina pared down a trade secrets suit accusing him of replicating the dining concept at another restaurant in Missouri, with a state judge throwing out all but one breach of contract claim against him.
-
February 18, 2026
Axsome Blocks Sleep Disorder Drug Generic Until 2040
Biopharmaceutical business Axsome Therapeutics Inc. has inked a deal to end lawsuits against Alkem Laboratories Ltd. over its generic version of a multimillion-dollar drug meant to help people with excessive daytime sleepiness, keeping the generic off the market for years.
-
February 18, 2026
This Firm Nabbed The Top Spot In Patent Activity Rankings
The law firm that secured the most utility patents in 2025, with 5,242 patents, retained the lead from 2024, although it experienced a slight dip in activity, according to a new report from Harrity Patent Analytics.
Expert Analysis
-
Attys Beware: Generative AI Can Also Hallucinate Metadata
In addition to the well-known problem of AI-generated hallucinations in legal documents, AI tools can also hallucinate metadata — threatening the integrity of discovery, the reliability of evidence and the ability to definitively identify the provenance of electronic documents, say attorneys at Law & Forensics.
-
Lessons From Fed. Circ. On Expert Testimony In Patent Cases
Several recent decisions from the Federal Circuit are notable for their treatment of expert testimony, with relevance to the three pillars of every patent case — infringement, invalidity and damages — and offer lessons on ensuring that expert testimony is both admissible and sufficient to support the jury's verdict, say attorneys at Honigman.
-
When Atty Ethics Violations Give Rise To Causes Of Action
Though the Model Rules of Professional Conduct make clear that a violation of the rules does not automatically create a cause of action, attorneys should beware of a few scenarios in which they could face lawsuits for ethical lapses, says Brian Faughnan at Faughnan Law.
-
TikTok Divestiture Deal Revolves Around IP Considerations
The divestiture deal between the U.S. and China to resolve a security dispute over TikTok's U.S. operations is seen as a diplomatic breakthrough, but its success hinges on the treatment of intellectual property and may set a precedent in the global contest over digital sovereignty and IP control, say attorneys at Brownstein Hyatt.
-
Trending At The PTAB: A Potential Barrier To Serial Challenges
New rules proposed by the U.S. Patent and Trademark Office may appear similar to previous rules at first glance, but are actually much broader in how they would limit petitioners' ability to challenge a patent more than once, say attorneys at Finnegan.
-
Fed. Circ. In September: The Printed Matter Doctrine Expands
The Federal Circuit’s recent decision in Bayer v. Mylan represents an extension of the doctrine that adding new words to an existing product or method will not support patentability unless there is a functional relationship, bringing new considerations for both patent holders and challengers, say attorneys at Knobbe Martens.
-
10 Quick Tips To Elevate Your Evidence Presentation At Trial
A strong piece of evidence, whether in the form of testimony or exhibit, is wasted if not presented effectively, so attorneys must prepare with precision to help fact-finders both retain the information and internalize its significance, says Allison Rocker at Baker McKenzie.
-
Series
Practicing Stoicism Makes Me A Better Lawyer
Practicing Stoicism, by applying reason to ignore my emotions and govern my decisions, has enabled me to approach challenging situations in a structured way, ultimately providing advice singularly devoted to a client's interest, says John Baranello at Moses & Singer.
-
Broader Eligibility For AI-Related Patents May Be Coming
A series of recent developments from the U.S. Patent and Trademark Office appears to signal that claims involving improvement in the operation of a machine learning model are now more likely to be considered patent-eligible, and that patent examiners may focus on questions of novelty and nonobviousness and less so on subject matter eligibility, say attorneys at Kilpatrick.
-
Series
The Biz Court Digest: Texas, One Year In
A year after the Texas Business Court's first decision, it's clear that Texas didn't just copy Delaware and instead built something uniquely its own, combining specialization with constitutional accountability and creating a model that looks forward without losing touch with the state's democratic and statutory roots, says Chris Bankler at Jackson Walker.
-
Series
Law School's Missed Lessons: Educating Your Community
Nearly two decades prosecuting scammers and elder fraud taught me that proactively educating the public about the risks they face and the rights they possess is essential to building trust within our communities, empowering otherwise vulnerable citizens and preventing wrongdoers from gaining a foothold, says Roger Handberg at GrayRobinson.
-
Adapting To USPTO's Reduction Of Examiner Interview Time
Reported changes to the U.S. Patent and Trademark Office's examiner performance appraisal plan will likely make interviews scarcer throughout the application process, potentially influencing patent allowance rates and increasing the importance of approaching each interview with a clear agenda and well-defined goals, say attorneys at Polsinelli.
-
What To Know About Interim Licenses In Global FRAND Cases
Recent U.K. court decisions have shaped a framework for interim licenses in global standard-essential patent disputes, under which parties can benefit from operating on temporary terms while a court determines the final fair, reasonable and nondiscriminatory terms — but the future of this developing remedy is in doubt, say attorneys at Fish & Richardson.
-
5 Crisis Lawyering Skills For An Age Of Uncertainty
As attorneys increasingly face unprecedented and pervasive situations — from prosecutions of law enforcement officials to executive orders targeting law firms — they must develop several essential competencies of effective crisis lawyering, says Ray Brescia at Albany Law School.
-
Anticipating FTC's Shift On Unfair Competition Enforcement
As the Federal Trade Commission signals that it will continue to challenge unfair or deceptive acts and practices under Section 5 of the FTC Act, but with higher evidentiary standards, attorneys counseling healthcare, technology, energy or pharmaceuticals clients should note several practice tips, says Thomas Stratmann at George Mason University.